Preliminary evidence of efficacy of a CRF1 receptor antagonist in the 7.5% CO2 model of anxiety. Program No. 250.5/01. 2009 Neuroscience Meeting Planner. Chicago, IL: Society for Neuroscience, 2009.

Dawson, G.R., Bailey, J.E., Papadopoulos, A, Diaper, A., Phillips, S.M., Schmidt, M., Van Der Ark, P., Dourish, C.T. and Nutt, D.J. (2009).